From: Enhancer alterations in cancer: a source for a cell identity crisis
Cancer type(s) | Epigenetic change | Reference(s) |
---|---|---|
Colon | Gains and losses of H3K4me1 | [81] |
Breast, cervical, colon, pancreatic, prostate, blood | Gains and losses of super-enhancers | |
Breast, lung, cervical | Gains and losses of DNA methylation | [79] |
Melanoma, breast, T-cell leukemia | Gains and losses of open chromatin (DNase) | [26] |
Breast | Gains and losses of H3K4me2, open chromatin | [84] |
T-cell acute lymphoblastic leukemia | Global chromatin compaction, reduced H3K27ac | [85] |
Breast, colon, laryngeal squamous cell | HOTAIR overexpression, gains of H3K27me3 | |
Hepatocellular | HOTTIP overexpression, increased HOXA13 overexpression | [89] |
Colon | CCAT1-L overexpression, chromatin looping to MYC |